Success for ITU researchers
01 April 2013
QEHB’s renowned Critical Care team is going strength to strength in its research efforts.
The 100-bed Critical Care unit is one of the largest single facilities of its kind in the world and treats some of our most seriously ill and injured patients.
The unit hosts several studies which are improving our understanding of various conditions, from brain injury to infection and lung injury.
Members of the team recently had a research paper accepted for publication in the prestigious New England Journal of Medicine for the OSCAR study. This study looks at the use of a treatment called high-frequency oscillation for patients with acute respiratory distress syndrome (ARDS).
Critical Care research lead Dr Tony Whitehouse said the publication reflected the high quality of research going on within the department: “We have worked very hard to make research an integral part of patient care here in critical care.
“Research offers huge benefits to our patients by giving them the chance to use treatments which are among the most advanced in the world, and in the long term we are expanding our understanding of illness, injury and the treatments we use.”
“It reflects the hard work by all the team, especially the research nurses who do much of the recruiting and sampling for these studies.
This comes at the same time as the department was named as the best critical care research unit in the West Midlands by the local Comprehensive Local Research Network (CLRN). The CLRN administers Government funding and support for research.
Two particular studies have also been highly successful in recruiting new patients.
The unit has recently been recognised as the fastest recruiter in the world for the SyNAPSe study, which is looking at the use of progesterone for patients with serious brain injury.
QEHB is also the fastest recruiter in the country for the HARP-2 study, which examine the use of a drug called Simvastatin for acute lung injury.